These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26158719)

  • 1. [Non-Pharmacological Interventions for the Prevention of Weight Gain in Schizophrenic Patients Treated with Antipsychotic Medication].
    Fink A; Cieslak S; Rosenbach F
    Psychiatr Prax; 2015 Oct; 42(7):359-69. PubMed ID: 26158719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-pharmacological interventions for preventing weight gain in patients with first episode schizophrenia or bipolar disorder: A systematic review.
    Nyboe L; Lemcke S; Møller AV; Stubbs B
    Psychiatry Res; 2019 Nov; 281():112556. PubMed ID: 31521840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder.
    Wong MM; Chen EY; Lui SS; Tso S
    Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):135-41. PubMed ID: 21983497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The first psychotic episode].
    Vacheron MN
    Encephale; 2013 Sep; 39 Suppl 2():S124-5. PubMed ID: 24084423
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Nothdurfter C; Eser D; Schüle C; Zwanzger P; Marcuse A; Noack I; Möller HJ; Rupprecht R; Baghai TC
    World J Biol Psychiatry; 2006; 7(3):162-70. PubMed ID: 16861142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-pharmacological interventions for weight gain in patients with schizophrenia taking antipsychotics].
    Attux C; Martini LC; Reis AF; Bressan RA
    Arq Bras Endocrinol Metabol; 2009 Jun; 53(4):391-8. PubMed ID: 19649375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schizophrenia and weight management: a systematic review of interventions to control weight.
    Faulkner G; Soundy AA; Lloyd K
    Acta Psychiatr Scand; 2003 Nov; 108(5):324-32. PubMed ID: 14531752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full circle-old drugs prove more beneficial than newer agents for schizophrenia: a case report.
    Veronin MA; Colson K; Roffman ME; Roman MW
    Issues Ment Health Nurs; 2012 Nov; 33(11):797-800. PubMed ID: 23146014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of metformin for prevention of weight gain in psychiatric populations: a review.
    Newall H; Myles N; Ward PB; Samaras K; Shiers D; Curtis J
    Int Clin Psychopharmacol; 2012 Mar; 27(2):69-75. PubMed ID: 21979790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of antipsychotic-associated weight gain.
    O'Keefe CD; Noordsy DL; Liss TB; Weiss H
    J Clin Psychiatry; 2003 Aug; 64(8):907-12. PubMed ID: 12927005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Weight gain during treatment with antipsychotics: clinical relevance, pathophysiology, and therapeutical strategies].
    Himmerich H; Schuld A; Pollmächer T
    Psychiatr Prax; 2004 Nov; 31 Suppl 2():S233-7. PubMed ID: 15586316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight gain on antipsychotic medication is associated with sustained use among veterans with schizophrenia.
    Monnelly EP; Fonda J; Gagnon DR; Chittamooru S; Lawler EV
    J Clin Psychopharmacol; 2015 Feb; 35(1):57-62. PubMed ID: 25514067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials.
    Caemmerer J; Correll CU; Maayan L
    Schizophr Res; 2012 Sep; 140(1-3):159-68. PubMed ID: 22763424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
    Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM
    Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted intervention to improve monitoring of antipsychotic-induced weight gain and metabolic disturbance in first episode psychosis.
    Thompson A; Hetrick SE; Alvarez-Jiménez M; Parker AG; Willet M; Hughes F; Gariup M; Gomez DL; McGorry PD
    Aust N Z J Psychiatry; 2011 Sep; 45(9):740-8. PubMed ID: 21827345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
    Schooler N; Rabinowitz J; Davidson M; Emsley R; Harvey PD; Kopala L; McGorry PD; Van Hove I; Eerdekens M; Swyzen W; De Smedt G;
    Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic-induced weight gain in patients with schizophrenia.
    Llewellyn DJ; Naughton F
    JAMA; 2008 Apr; 299(16):1898-9; author reply 1899-900. PubMed ID: 18430905
    [No Abstract]   [Full Text] [Related]  

  • 18. [Successful quetiapine therapy in psychotic patients with mood elevation].
    Kecskés I
    Neuropsychopharmacol Hung; 2009 Dec; 11(4):259-63. PubMed ID: 20150663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [First-episode psychosis, cognitive difficulties and remediation].
    Vidailhet P
    Encephale; 2013 Sep; 39 Suppl 2():S83-92. PubMed ID: 24084427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.